GlassScriptPhysician profile
Jordan Reilly
NPI 1174053458
$5,405.86
in general payments reported to CMS, 2019-2025
8 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2024: $5,015 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,250 · Travel and Lodging: $1,607 · Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,250.00 |
| Travel and Lodging | $1,606.52 |
| Food and Beverage | $263.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,049.16 | 2024-2025 | |
| Kci USA, INC. | $108.38 | 2019 | |
| Teleflex LLC | $71.98 | 2019 | |
| Silk Road Medical, INC. | $52.53 | 2019 | |
| Bard Peripheral Vascular, INC. | $52.53 | 2019 | |
| Acera Surgical, INC. | $29.42 | 2025 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $21.44 | 2025 | Ribfix Blu Advantage |
| Kerecis Limited | $20.42 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Reilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.